我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

抽象的

Clinical Trial Progression in Indonesia: an Observational Study of Records from Clinical Trial Registries Databases

Mario Micheli

This report presents an outline on the progress of clinical tests in land supported information assessment from clinical trial registries. Study records that were registered up to December twenty six, 2018, were extracted from 3 clinical test registries (ClinicalTrials.gov, ISRCTN written record, and EudraCT) and a clinical test register (WHO International Clinical Trials written record Platform (ICTRP)) with the keyword “Indonesia”. a complete of 505 records comprised of 402 interventional studies and 103 experimental studies were found and analyzed. The top 5 noninfectious diseases (NCDs) studied were cancers, diabetes, internal organ diseases, cardiovascular disease, and channel diseases, whereas the highest 5 infectious diseases (IDs) were protozoal infection, infectious disease, vaccines for IDs, HIV, and dengue. Remarkably, the proportion of regional studies (within land only) was beyond that of multiregional studies (including areas outside of Indonesia) normally. This trend became most apparent once the issue of national laws on Material Transfer Agreements (MTA) and alternative rules. Upon nearer scrutiny, regional clinical trials and multiregional clinical trials (MRCTs) in land differed in terms of support, target population and size, interventions, and study phases.